ERBB2 and metastatic malignant neoplasm in the lymph nodes: As we expected, aggressive clinicopathological parameters, such as negative PR status, positive Her2 status, tumour size>2 cm, lymph node metastasis and clinical stage II–IV, were associated with worse survival in the univariate Cox hazards regression analysis (Table 4).